Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/314362 
Year of Publication: 
2024
Series/Report no.: 
ODI Report
Publisher: 
ODI, London
Abstract: 
Access to affordable, essential medicines is crucial for public health, yet remains a significant challenge across Africa. High prices, driven by fragmented procurement and limited local manufacturing, hinder healthcare systems. The African Continental Free Trade Area (AfCFTA) presents a unique opportunity to transform the pharmaceutical sector in Africa and address these issues. This report examines the role of the AfCFTA in facilitating the procurement of essential pharmaceuticals and vaccines in Africa. It analyses the impact of the AfCFTA's rules of origin (RoOs) on the cost of imported medicines and vaccines, and explores how the landmark agreement can be used to support the development and growth of local pharmaceutical manufacturing capacity and value chains.
Creative Commons License: 
cc-by-nc-nd Logo
Document Type: 
Research Report

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.